XOMA (US) LLC to Present at Credit Suisse First Boston 2013 Antibody Day

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BERKELEY, Calif., May 6, 2013 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today that Paul Rubin, the Company's Senior Vice President, Research and Development, and Chief Medical Officer, is scheduled to present at the Credit Suisse 2013 Antibody Day on May 10, 2013 at 8:30 a.m. Eastern time.

Help employers find you! Check out all the jobs and post your resume.

Back to news